title: [Innovative wound care--new studies to increase evidence].
abstract: BACKGROUND
  Today numerous products for wound care are available. A research-based evidence on which the clinician can base its selection, is still missing. In the guidelines randomized controlled trials (RCTs) have been left out.
  
  
  METHODS
  In the overview three current RCT with products for the treatment of chronically venous ulcers will be presented.
  
  
  CONCLUSIONS
  The pre-mentioned studies show, that it is possible to provide a basis for evidence-based treatment in wound healing. The effective value ofa wound treatment based on the costs and benefits must be defined by the health system. But products, for which data from randomized trials exist, should be evaluated in a different way to products, for which there are no such data.
authors.forename: K
authors.initials: K
authors.lastname: Kroger
authors.forename: M
authors.initials: M
authors.lastname: Storck
authors.forename: A
authors.initials: A
authors.lastname: Risse
mesh_terms: D015415:Biomarkers; D003362:Cost-Benefit Analysis / Q000191:economics; D019317:Evidence-Based Medicine / Q000191:economics; D006801:Humans; D009313:National Health Programs / Q000191:economics; D016032:Randomized Controlled Trials as Topic; D014647:Varicose Ulcer / Q000191:economics / Q000628:therapy*; D014945:Wound Healing / Q000502:physiology
chemical_list: D015415:Biomarkers